share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰制药 | 4：持股变动声明-董事 SACHS BRUCE I
美股sec公告 ·  04/17 16:11
Moomoo AI 已提取核心信息
In a recent transaction, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a stock transaction on April 15, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.
In a recent transaction, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a stock transaction on April 15, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.
在最近的一笔交易中，与Vertex Pharmicals Inc.（VRTX）关联的布鲁斯·萨克斯于2024年4月15日执行了一项股票交易。公告中没有披露有关股票性质、交易股票数量、交易价格以及交易后由此产生的所有权的具体细节。这些信息对于投资者了解交易对其投资决策的潜在影响至关重要。
在最近的一笔交易中，与Vertex Pharmicals Inc.（VRTX）关联的布鲁斯·萨克斯于2024年4月15日执行了一项股票交易。公告中没有披露有关股票性质、交易股票数量、交易价格以及交易后由此产生的所有权的具体细节。这些信息对于投资者了解交易对其投资决策的潜在影响至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息